Nemati A, Dadpour B, Etemad L, Mousavi S, Alizadeh Ghomsari A, Mousavi S
J Prev (2022). 2024; 46(1):103-120.
PMID: 39249718
DOI: 10.1007/s10935-024-00804-z.
Lukacisinova A, Reissigova J, Ortner-Hadziabdic M, Brkic J, Okuyan B, Volmer D
BMC Geriatr. 2024; 24(1):240.
PMID: 38454372
PMC: 10921596.
DOI: 10.1186/s12877-024-04742-7.
Alwafi H
Saudi Pharm J. 2023; 31(8):101670.
PMID: 37576854
PMC: 10415227.
DOI: 10.1016/j.jsps.2023.06.003.
Babicki M
Int J Environ Res Public Health. 2022; 19(22).
PMID: 36429598
PMC: 9690623.
DOI: 10.3390/ijerph192214879.
Jaqua E, Nguyen V, Scherlie N, Dreschler J, Labib W
Addict Health. 2022; 14(1):62-67.
PMID: 35573758
PMC: 9057647.
DOI: 10.22122/ahj.v14i1.1311.
Community Based Interventions for Problematic Substance Use in Later Life: A Systematic Review of Evaluated Studies and Their Outcomes.
Hafford-Letchfield T, McQuarrie T, Clancy C, Thom B, Jain B
Int J Environ Res Public Health. 2020; 17(21).
PMID: 33143159
PMC: 7663344.
DOI: 10.3390/ijerph17217994.
The pattern of substance abuse in Thai elderly: Ramathibodi Poison Center.
Ruangritchankul S, Srisuma S
SAGE Open Med. 2019; 7:2050312119873513.
PMID: 31516704
PMC: 6719469.
DOI: 10.1177/2050312119873513.
Profile of drug users in the residential treatment centers of Tehran, Iran.
Akbari H, Roshanpajouh M, Nourijelyani K, Mansournia M, Rahimi-Movaghar A, Yazdani K
Health Promot Perspect. 2019; 9(3):248-254.
PMID: 31508346
PMC: 6717926.
DOI: 10.15171/hpp.2019.34.
Descriptive, observational study of pharmaceutical and non-pharmaceutical arrests, use, and overdoses in Maine.
Simpson K, Moran M, Foster M, Shah D, Chung D, Nichols S
BMJ Open. 2019; 9(4):e027117.
PMID: 31036710
PMC: 6501962.
DOI: 10.1136/bmjopen-2018-027117.
Prevalence of Concurrent Prescription Opioid and Hazardous Alcohol Use Among Older Women: Results from a Cross-Sectional Study of Community Members.
Serdarevic M, Gurka K, Striley C, Vaddiparti K, Cottler L
J Community Health. 2018; 44(1):172-177.
PMID: 30145703
PMC: 7063756.
DOI: 10.1007/s10900-018-0569-y.
Impact of Laws Regulating Pain Clinics on Opioid Prescribing and Opioid-Related Toxicity Among Texas Medicare Part D Beneficiaries.
Raji M, Kuo Y, Chen N, Hasan H, Wilkes D, Goodwin J
J Pharm Technol. 2018; 33(2):60-65.
PMID: 29888344
PMC: 5990015.
DOI: 10.1177/8755122516686226.
What can we learn about brain donors? Use of clinical information in human postmortem brain research.
Sullivan K, Pantazopoulos H, Liebson E, Woo T, Baldessarini R, Hedreen J
Handb Clin Neurol. 2018; 150:181-196.
PMID: 29496141
PMC: 7703525.
DOI: 10.1016/B978-0-444-63639-3.00014-1.
Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use.
Adan A, Marquez-Arrico J, Gilchrist G
Health Qual Life Outcomes. 2017; 15(1):209.
PMID: 29061151
PMC: 5654090.
DOI: 10.1186/s12955-017-0781-y.
Prevalence of substance abuse and socio-economic differences in substance abuse in an Australian community-dwelling elderly sample.
Li W, Caltabiano N
Health Psychol Open. 2017; 4(1):2055102917708136.
PMID: 28567302
PMC: 5438039.
DOI: 10.1177/2055102917708136.
A Systematic Review of Opioid and Benzodiazepine Misuse in Older Adults.
Maree R, Marcum Z, Saghafi E, Weiner D, Karp J
Am J Geriatr Psychiatry. 2016; 24(11):949-963.
PMID: 27567185
PMC: 5069126.
DOI: 10.1016/j.jagp.2016.06.003.
Trends in Opioid Prescriptions Among Part D Medicare Recipients From 2007 to 2012.
Kuo Y, Raji M, Chen N, Hasan H, Goodwin J
Am J Med. 2015; 129(2):221.e21-30.
PMID: 26522794
PMC: 4718856.
DOI: 10.1016/j.amjmed.2015.10.002.
Mortality among older adults with opioid use disorders in the Veteran's Health Administration, 2000-2011.
Larney S, Bohnert A, Ganoczy D, Ilgen M, Hickman M, Blow F
Drug Alcohol Depend. 2015; 147:32-7.
PMID: 25575652
PMC: 4310721.
DOI: 10.1016/j.drugalcdep.2014.12.019.
Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.
Berretta S, Heckers S, Benes F
Schizophr Res. 2014; 167(1-3):91-7.
PMID: 25458567
PMC: 4427537.
DOI: 10.1016/j.schres.2014.10.019.
The use of virtual reality in craving assessment and cue-exposure therapy in substance use disorders.
Hone-Blanchet A, Wensing T, Fecteau S
Front Hum Neurosci. 2014; 8:844.
PMID: 25368571
PMC: 4201090.
DOI: 10.3389/fnhum.2014.00844.